UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000019596
Receipt No. R000022618
Scientific Title Phase II study of implantation of carmustine wafers, followed by radiation therapy and concomitant temozolomide and bevacizumab for newly diagnosed glioblastoma.
Date of disclosure of the study information 2016/01/14
Last modified on 2018/05/05 09:07:44

No. Disposal Last modified on Item of update
1 Insert 2015/11/02 10:46:24
2 Update 2015/11/30 11:35:59 Interventions/Control_1
3 Update 2015/11/30 11:37:26 Anticipated trial start date
4 Update 2015/11/30 11:38:52 Date of disclosure of the study information
5 Update 2015/12/26 19:51:41 Acronym
Acronym
6 Update 2015/12/26 19:53:29 Date of disclosure of the study information
7 Update 2016/01/19 23:12:09 Acronym
Acronym
8 Update 2016/11/05 14:20:44 Key exclusion criteria
Key exclusion criteria
9 Update 2017/05/28 14:50:04 Recruitment status
10 Update 2017/11/03 17:20:58 Target sample size
11 Update 2018/05/05 09:05:25 Name of primary sponsor
Organization
12 Update 2018/05/05 09:07:44 Recruitment status
Last follow-up date


Contact us.